Digestive System Diseases Terminated Phase 3 Trials for ABT-869 (DB06080)

Also known as: Digestive System Disease

IndicationStatusPhase
DBCOND0033030 (Digestive System Diseases)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01009593Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)Treatment